“Early detection can reduce lung cancer death rates by 20% — that’s significant,” Dr. Gorbatov says. “In some cases when we ...

The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung ...

Early lung cancer and lung nodule detection are critical for fighting this disease. In this segment, Dr. Chetana Pendkar from ...

The Food and Drug Administration (FDA) has approved Imfinzi ® (durvalumab), as a single agent, for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has ...

In an interview with Targeted OncologyT, Rupesh Kotecha, MD, discussed a study focused on how systemic therapy selection ...

A pooled analysis of the TROPION-Lung05 phase 2 and the TROPION-Lung01 phase 3 trials showed that Daiichi Sankyo (DSKYF.PK) and ...

Read: AdventHealth continues to recruit and retain RNs. It’s the only FDA-approved fluorescent imaging technology t ...

Cancer cells impair monocyte-mediated T-cell activation by disrupting inflammatory pathways in the tumor microenvironment.

Zenocutuzumab received accelerated approval from the FDA for the agent to treat non-small cell lung cancer (NSCLC) or ...

Other parts of India were similarly affected: 89 of 252 cities had air capable of causing breathing discomfort, as per the Central ... to cause cancer, and it is the reason why lung cancer is ...

The American Cancer Society says lung cancer accounts for one in five of all cancer deaths, making it the leading cause of cancer deaths in the nation. We learn more about the screening process ...

“Avelumab’s profile, coupled with AU-007 and low-dose, subcutaneous aldesleukin, could potentially offer a new therapeutic option for patients with advanced or metastatic PD-L1+ non-small cell lung ...